Abstract
The Indian government has announced amendments to the Drugs and Cosmetics Rules that require testing for hepatitis C virus (HCV) antibodies in all blood products in the country's blood banks. The amendment is set to take effect on June 1 2001, according to the Government, which plans to supply free HCV antibody-testing kits to all public-sector blood banks. Blood products in India currently undergo mandatory testing for the hepatitis B surface antigen, HIV, malaria and syphilis. CK (http://id.medscape.com/23593.rhtml?srcmp=id-032301)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
